WHAT IS IMPROVE AND OPTIMIZE?
For any dynamic business, even the simplest supply chains can evolve at a very rapid rate. Be it through enforced or elective changes in suppliers, processes, products, portfolios or geographies, what was once an efficiently operating manufacture and supply approach, can quickly become inefficient, costly and uncompetitive.
Impact Supply Chain Partners has significant experience improving and optimizing healthcare supply chains for major global healthcare companies in the following areas:
- Cost and efficiency improvements
- Product & process improvement
- Fit-for-purpose quality systems
- Complexity management
- Value engineering
The primary focus on everything we do is focused on positively impacting your business performance. Our partnership with you on these service areas will drive positive impact to:
PROFITABILITY – margin expansion, cost savings
OPERATIONAL EFFICIENCY – improve process capability, reduce waste
REPRESENTATIVE ASSIGNMENTS
COST SAVINGS THROUGH TECH TRANSFER
Post licensing deal optimisation of supply chain, exercising option to relocate complex intermediate and finished product manufacturing from sellers original supply site. Supply changes resulted in 30% reduction in COGs and delivered a cost saving of US$10m to the brand.
COMPLEXITY MANAGEMENT TO RELEASE CAPACITY
4-week assignment completing SKU-level portfolio complexity optimisation on leading global VMS brand which improved packaging line efficiency at three global supply sites leading to ~20% increased pack output during COVID demand spike.
MARGIN EXPANSION
Enhanced margins across key brands by reducing production costs without compromising valued features. Cross-functional teams assessed cost-saving opportunities and consumer preferences. Discovering that foil print on cartons added US$200k in expenses annually. Senior leaders adopted recommendation to switch to a standard silver, saving US$200k yearly and improving margins. Despite the change, consumers remained satisfied with the product, ensuring brand equity.